China’s Fosun pulls out of $300 million healthcare deals amid negative sentiment
According to sources, both deals were at an advanced stage, and Fosun had formally proposed terms for acquiring a stake in the companies, on...Read More
Showing posts with label Healthcare/Biotech-Industry-Economic Times. Show all posts
Showing posts with label Healthcare/Biotech-Industry-Economic Times. Show all posts
ICMR sets up 11 teams to monitor antigen tests
The 11 teams set up by the Indian Council of Medical Research comprise of epidemiologists along with doctors from the All India Institute of...Read More
Sero survey findings not shared with ICMR’s panel: DCS Reddy
“The findings of the data have not been shared with the ICMR epidemiology and surveillance working group as yet,” DCS Reddy, chairman of the...Read More
Private hospitals seek Uddhav Thackeray’s help to lift cap on treatment charges
The state government passed the order under the Disaster Management Act capping the rates that private and trust-run hospitals can charge fo...Read More
No imports of second-hand ventilators now
The ministry of environment, forest and climate change has withdrawn its April 1 order that allowed imports of second-hand ventilators while...Read More
ICMR seeks proposals, to fund plasma therapy trials at 20 govt facilities
ICMR will choose 20 healthcare facilities, largely government-run hospitals, across India to begin clinical trials for convalescent plasma t...Read More
Covid-19 fight: After rush for antibody kits come concerns
With reports that the rapid antibody tests may miss infections and can falsely produce negative results in infected patients, ICMR is studyi...Read More
Covid-19 impact: Drugs essential, ancillaries not so, means supplies take a hit
National chemists and druggists association and industry lobby groups have urged the government to put all ancillary goods required for medi...Read More
Covid-19 battle: Govt may Lift Hydroxychloroquine export ban
The government may place it in the restricted list which means that exports will not be banned and will be allowed for companies which apply...Read More
Covid-19: Forget healing touch, pharma gets it rough
The national lockdown has hit pharmaceutical companies hard as restrictions on movement of goods and people imposed by the police led to a d...Read More
Coronavirus Pandemic: Healthcare professionals take to social media to express their despair
Highlight lack of protective gear and harassment they are facing amid pandemic from Healthcare/Biotech-Industry-Economic Times https://ift...Read More
Covid-19: Export curbs on imported API drugs under review
The commerce and industry ministry is studying a proposal to allow exports of drugs from active pharmaceutical ingredients (API) which have ...Read More
Covid-19: ESIC hospitals may set up 400 isolation beds
The government has proposed setting up 400 isolation beds in 27 labour ministry-run ESIC health institutions across India to be used for ge...Read More
Covid-19: Pharma companies ask Govt to lift API's export restrictions
Pharmaceutical lobby groups have urged the government to lift restrictions on export of active pharmaceutical ingredients (APIs) and formul...Read More
Fake Covid-19 'gyaan' goes viral
Misinformation on Covid-19 including home remedies, conspiracy theories, false government advisories, and misleading narratives around China...Read More
Setting up pharma R&D bases in India will soon be incentivised
Government seeks feedback from top pharmaceutical companies as it considers making regulatory changes to offer specific tax sops for special...Read More
Covid-19 impact: Government panel lists essential drugs that can run out
A high-level government committee, which submitted its report to the Department of Pharmaceuticals (DoP) last week, reviewed 54 drugs and sa...Read More
NPPA tells chief secys to keep tabs on API availability
In a letter to the chief secretaries, the National Pharmaceutical Pricing Authority (NPPA) has asked them to ensure that there is no violati...Read More
18% of Indian pharma launches to be delayed in US, says Crisil
The warning letter issued by USFDA to large pharma companies more than doubled in the first 10 months of 2019 compared with the previous yea...Read More
Exaggerated drug ads to bring fines, stringent charges
Ministry sets up panel to suggest stronger criminal procedures against violators. At present, penalties for false claims include “imprisonme...Read More
Subscribe to:
Posts
(
Atom
)